Agios Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Agios Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker AGIO.
Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is...
Can you invest in Agios Pharmaceuticals, Inc.?
Yes. Agios Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker AGIO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Agios Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.